Physician profile
Robert Kohl
NPI 1689628901
$204.42
in general payments reported to CMS, 2019-2025
7 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $15.10 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $204.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $204.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $51.18 | 2025 | Keytruda, Keytruda Qlex |
| Tactile Systems Technology INC | $33.71 | 2025 | Nimbl, Flexitouch Plus |
| Janssen Biotech, INC. | $33.50 | 2023-2025 | Tecvayli, Darzalex, Talvey |
| Abbvie INC. | $28.61 | 2025 | |
| Jazz Pharmaceuticals INC. | $21.80 | 2025 | |
| Incyte Corporation | $21.40 | 2025 | Niktimvo, Jakafi |
| Bayer Healthcare Pharmaceuticals INC. | $14.22 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kohl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.